Cerebromicrovascular mechanisms contributing to long COVID: implications for neurocognitive health
Mónika Fekete,
No information about this author
Andrea Ceglédi,
No information about this author
Ágnes Szappanos
No information about this author
et al.
GeroScience,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 7, 2025
Abstract
Long
COVID
(also
known
as
post-acute
sequelae
of
SARS-CoV-2
infection
[PASC]
or
post-COVID
syndrome)
is
characterized
by
persistent
symptoms
that
extend
beyond
the
acute
phase
infection,
affecting
approximately
10%
to
over
30%
those
infected.
It
presents
a
significant
clinical
challenge,
notably
due
pronounced
neurocognitive
such
brain
fog.
The
mechanisms
underlying
these
effects
are
multifactorial,
with
mounting
evidence
pointing
central
role
cerebromicrovascular
dysfunction.
This
review
investigates
key
pathophysiological
contributing
cerebrovascular
dysfunction
in
long
and
their
impacts
on
health.
We
discuss
how
endothelial
tropism
direct
vascular
trigger
dysfunction,
impaired
neurovascular
coupling,
blood–brain
barrier
disruption,
resulting
compromised
cerebral
perfusion.
Furthermore,
appears
induce
mitochondrial
enhancing
oxidative
stress
inflammation
within
cells.
Autoantibody
formation
following
also
potentially
exacerbates
injury,
chronic
ongoing
compromise.
These
factors
collectively
contribute
emergence
white
matter
hyperintensities,
promote
amyloid
pathology,
may
accelerate
neurodegenerative
processes,
including
Alzheimer’s
disease.
emphasizes
critical
advanced
imaging
techniques
assessing
health
need
for
targeted
interventions
address
complications.
A
deeper
understanding
essential
advance
treatments
mitigate
its
long-term
consequences.
Language: Английский
Comparative Analysis of Virology and Pathogenesis of SARS-CoV-2 and HIV Infections: Implications for Public Health and Treatment Strategies
Infection and Drug Resistance,
Journal Year:
2025,
Volume and Issue:
Volume 18, P. 269 - 283
Published: Jan. 1, 2025
Introduction:
Coronavirus
Disease
19
(COVID-19),
caused
by
the
Severe
Acute
Respiratory
Syndrome
2
(SARS-CoV
-2),
and
Human
Immunodeficiency
Virus
(HIV)
are
significant
21st-century
pandemics
with
distinct
virological
clinical
characteristics.COVID-19
primarily
presents
as
an
acute
respiratory
illness,
while
HIV
leads
to
chronic
immune
suppression.Understanding
their
differences
can
enhance
public
health
strategies
treatment
approaches.Purpose:
This
narrative
review
compares
virology,
transmission,
responses,
outcomes
of
SARS-CoV-2
inform
interventions.Methods:
A
was
conducted,
synthesizing
data
from
peer-reviewed
literature
expert
commentary
2010
2024.Databases
such
PubMed,
Cochrane
Library,
Google
Scholar
were
searched
for
relevant
studies.Results:
spreads
through
airborne
droplets
contaminated
surfaces,
transmits
direct
contact
infected
bodily
fluids.The
response
involves
both
innate
adaptive
systems,
potentially
leading
a
cytokine
storm
in
severe
cases.In
contrast,
evades
system
integrating
into
host
cells,
resulting
infection
progressive
deterioration.Treatment
focuses
on
symptom
management
prevention,
antiviral
medications
vaccines
playing
crucial
roles.Conversely,
relies
antiretroviral
therapy
(ART)
suppress
viral
replication
maintain
function.
Conclusion:The
highlights
nature
versus
progression
HIV.Tailored
prevention
essential
effective
disease
management.Recommendations:
Public
should
address
unique
transmission
routes
viruses.Further
research
vaccine
development
therapeutic
interventions
is
critical
improving
management.
Language: Английский
Multidisciplinary collaborative guidance on the assessment and treatment of patients with Long COVID: A compendium statement
PM&R,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 22, 2025
Abstract
Background
In
2021,
the
American
Academy
of
Physical
Medicine
and
Rehabilitation
established
Multi‐Disciplinary
Post‐Acute
Sequelae
SARS‐CoV‐2
Infection
Collaborative
to
provide
guidance
from
Long
COVID
clinics
for
evaluation
management
COVID.
The
collaborative
previously
published
eight
consensus
statements
using
a
primarily
symptom‐based
approach.
However,
symptoms
most
often
do
not
occur
in
isolation.
Aims
This
compendium
aims
equip
clinicians
with
an
efficient,
up‐to‐date
clinical
resource
evaluating
managing
adults
experiencing
symptoms.
primary
intended
audience
includes
physiatrists,
care
physicians,
other
who
first‐line
assessment
symptoms,
especially
settings
where
subspecialty
is
readily
available.
provides
holistic
framework
management,
symptom‐specific
considerations,
updates
on
prevalence,
health
equity,
disability
pathophysiology,
emerging
evidence
regarding
treatments
under
investigation.
Because
closely
resembles
infection‐associated
chronic
conditions
(IACCs)
such
as
myalgic
encephalomyelitis/chronic
fatigue
syndrome,
this
may
also
be
helpful
these
related
conditions.
Methods
Guidance
was
developed
by
collaborative's
modified
Delphi
multidisciplinary
group
whose
members
include
pulmonologists,
cardiologists,
psychiatrists,
neuropsychologists,
neurologists,
occupational
therapists,
physical
speech
language
pathologists,
patients,
government
representatives.
Over
40
centers
are
represented
collaborative.
Results
defined
National
Academies
Sciences,
Engineering,
“an
IACC
that
occurs
after
infection
present
at
least
3
months
continuous,
relapsing
remitting,
or
progressive
disease
state
affects
one
more
organ
systems.”
current
global
prevalence
estimated
6%.
Higher
has
been
identified
among
female
gender,
certain
racial
ethnic
groups,
individuals
live
nonurban
areas.
anyone
can
develop
being
infected
virus.
wide
variety
symptom
clusters.
common
exaggerated
diminished
energy
windows,
postexertional
malaise
(PEM)/postexertional
exacerbation
(PESE),
cognitive
impairment
(brain
fog),
dysautonomia,
pain/myalgias,
smell
taste
alterations.
Holistic
should
traditional
history,
examination,
additional
diagnostic
testing,
indicated.
A
positive
COVID‐19
test
during
acute
required
diagnose
COVID,
currently,
there
no
single
laboratory
finding
definitively
confirming
ruling
out
diagnosis
basic
recommended
all
patients
possible
consideration
labs
procedures
guided
patient's
specific
Current
strategies
focus
supportive
care.
Critical
considerations
conservation
addressing
comorbidities
modifiable
risk
factors.
Additionally,
(1)
it
essential
validate
experience
reassurance
their
taken
seriously
because
many
have
had
dismissed
loved
ones
clinicians;
(2)
activity
recommendations
must
carefully
tailored
tolerance
overly
intense
trigger
PEM/PESE
worsened
muscle
damage;
(3)
treatment
delivered
humility
persistent
unknowns
To
date,
limited
data
guide
medication
specifically
context
As
such,
use
generally
follows
standard
practice
indications
dosing,
extra
attention
prioritize
patient
preference
via
shared
decision‐making
cautious
medications
improve
some
(eg,
cognitive/attention
impairment)
but
worsen
PEM/PESE).
Numerous
trials
investigating
treatments.
return‐to‐work
process
challenging
fluctuate,
vary
nature,
affect
multiple
functional
areas
cognitive),
manifest
“invisible
disability”
acknowledged
employers
coworkers.
Clinicians
help
return
work
identifying
suitable
workplace
accommodations
resources,
providing
necessary
documentation,
recommending
vocational
therapy
when
needed.
If
efforts
unsuccessful
significantly
worsens
impedes
recovery,
applying
warranted.
recognized
potential
Americans
Disabilities
Act.
Conclusion
contribute
overall
well‐being
manner
acknowledges
challenges
faced
uncertainties
field.
For
detailed
information
readers
reference
statements.
Language: Английский
CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF LONG-COVID DEVELOPMENT PATTERNS IN PATIENTS OF DIFFERENT AGE GROUPS
Eastern Ukrainian Medical Journal,
Journal Year:
2024,
Volume and Issue:
12(2), P. 431 - 440
Published: Jan. 1, 2024
The
aim
of
the
study
was
to
clarify
patterns
Long-COVID
development
after
coronavirus
disease.
Materials
and
methods.
A
questionnaire
examination
people
with
COVID-19
analysis
medical
records
were
conducted.
Taking
into
account
inclusion
exclusion
criteria,
77
women
men
who
had
suffered
from
disease
included
in
group.
questions
about
age,
gender,
chronic
diseases
before
onset
disease,
vaccination
status,
complaints
general
condition
medication,
smoking,
subjects'
assessment
changes
physical
endurance
overall
quality
life
comparison
group
consisted
practically
healthy
appropriate
age.
Results.
In
period
up
3
months
mainly
aged
31-40
years,
but
increasing
time,
older
patients
(51–60
years)
began
predominate.
main
groups
(general,
respiratory,
neuropsychiatric,
cardiovascular)
presented
by
subjects
mostly
vaccinated,
rate
among
them
exceeding
80%.
Diseases
cardiovascular
system
recorded
51–60
regardless
duration
Decreased
a
decline
according
subjective
observed
40
60
proportion
vaccinated
being
81.3%.
At
same
level
smoking
above
low.
Conclusions.
majority
reported
women.
most
common
weakness
(46.8%),
anxiety
(44.2%),
mood
disorders
(41.6%),
headache
(28.6%),
shortness
breath
(23.4%),
palpitations
at
rest
dizziness
(16.7%).
there
smaller
those
cognitive
impairment
(impaired
concentration
attention
–
7.8%,
memory
14.3%),
gastrointestinal
(13.0%),
muscle
pain
(13.0%).
(80.0%),
percentage
smokers
low
(18.5%).
Language: Английский
Pre-or co-SARS-CoV-2 Infections Significantly Increase Severe Dengue Virus Disease Criteria: Implications for Clinicians
Pathogens,
Journal Year:
2024,
Volume and Issue:
13(7), P. 573 - 573
Published: July 10, 2024
Few
studies
have
investigated
whether
SARS-CoV-2
infections
increase
the
incidence
of
dengue
haemorrhagic
fever/shock
syndrome
(DHF/DSS)
and/or
severe
(SD)
in
virus
(DENV)-infected
patients.
This
study
was
performed
on
a
site
with
high
incidences
classical
dengue,
but
relatively
few
DHF/DSS
or
SD
cases
as
defined
by
WHO
1997
2009
criteria,
respectively.
Clinical,
haematological/biochemical,
and
viral
diagnostic
data
were
collected
from
febrile
patients
before,
during,
after
COVID-19
epidemic
to
assess
(a)
DENV-infected
prior
(b)
DENV-SARS-CoV-2-co-infected
had
increased
SD/DHF/DSS
using
logistic
regression
machine
learning
models.
Higher
numbers
DHF/DSS/SD
occurred
during
epidemic,
particularly
males
18-40-year-olds.
Significantly
symptoms
haemoconcentration
(
Language: Английский
A multimodal approach for treating post-acute infectious syndrome
Brain medicine :,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 7
Published: Aug. 30, 2024
Long-term
complications,
such
as
extensive
fatigue
and
cognitive
issues,
are
known
from
various
infections,
including
SARS-CoV-2,
influenza
virus,
or
Borrelia
burgdorferi
.
The
pathology
is
mostly
unknown
differs
between
patients.
Unfortunately,
there
currently
no
common
effective
treatment.
In
this
perspective,
we
imply
that
post-acute
infectious
syndromes
due
to
a
variety
of
factors,
among
others
diminished
tissue
perfusion,
infiltration
by
viruses,
inflammation,
oxidative
stress,
not
one
specific
biomarker
can
be
used
measure
these
syndromes.
Thus,
suggest
score
based
on
number
criteria/factors
should
assess
Consequently,
probably
single
treatment
treat
group
patients,
multimodal
regimen
comprising
combination
pharmacotherapy,
metformin
naltrexone
with
anti-inflammatory
effects,
alongside
physical
therapies
extracorporeal
apheresis
transcutaneous
neurotherapy.
This
combined
approach
aims
reduce
levels
enhance
functions.
implies
reset
the
systems
achieved
for
Language: Английский
Systems Thinking, Causal Loop Diagram, and Systems Dynamic in Public Health Challenges: Navigating Long COVID Syndrome and Sense of Smell in LGBTQIA+ Communities
Behnaz Akbari,
No information about this author
Jessica M. Wang,
No information about this author
Namdar Baghaei‐Yazdi
No information about this author
et al.
Public Health Challenges,
Journal Year:
2024,
Volume and Issue:
3(3)
Published: Sept. 1, 2024
ABSTRACT
Background
The
coronavirus
pandemic
has
profoundly
affected
global
health,
economic
stability,
and
environmental
sustainability.
Despite
these
challenges,
significant
gaps
in
data
remain,
particularly
effectively
assessing
engaging
diverse
communities
such
as
color,
LGBTQIA+
individuals,
low‐income
groups.
This
shortage
of
comprehensive
research
limits
our
capacity
to
undertake
sensitive
studies,
specifically
dealing
with
the
complexities
long
COVID,
which
some
individuals
continue
suffer
from
after
their
initial
recovery.
Objective
review
delves
into
ongoing
repercussions
long‐term
COVID‐19,
a
postinfectious
syndrome
marked
by
neurological
symptoms
cognitive
deficits
sensory
impairments,
may
last
well
beyond
acute
phase
illness.
These
frequently
overlap
mental
health
issues
(e.g.,
anxiety
depression),
can
aggravate
socioeconomic
challenges
faced
vulnerable
populations,
especially
within
LGBTQA+
communities.
Methods
To
tackle
complex
interactions,
we
have
introduced
novel
public
framework:
model‐based
systems
thinking
(MBST),
incorporates
System
Dynamics
causal
loop
diagrams
(CLD).
Results
Discussion
articles
were
selected
on
basis
discussion
COVID‐19‐associated
anosmia,
exploration
olfactory
dysfunction
alongside
neurocognitive
disorders,
experienced
LGBQA+
approach
offers
robust
framework
for
dissecting
intricate
ties
between
factors,
outcomes,
extended
recovery
trajectories
associated
particular
focus
dysfunction.
We
also
explore
strategies
make
models
more
accessible
healthcare
providers
communities,
encouraging
its
broader
adoption.
Conclusion
Long
COVID's
impact
marginalized
highlights
urgent
need
adopting
models.
Additionally,
this
article
calls
concerted
effort
all
experts
foster
multidisciplinary,
team‐based
implement
effective
support
measures
COVID‐19
survivors
across
mainly
focusing
scientific,
social,
behavioral
face.
Language: Английский
Trends and cross-country disparity in the burden of COVID-19 between 2020 and 2021: a systematic analysis for the Global Burden of Disease Study 2021
Qiuying Chen,
No information about this author
Lanyue Pan,
No information about this author
Yuan Zhan
No information about this author
et al.
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 24, 2024
Abstract
Background
Coronavirus
disease
2019
(COVID-19)
has
led
to
extensive
repercussions
on
global
health
and
economic
systems.
In
this
study,
we
aim
provide
an
analysis
of
global,
national,
regional
COVID-19
incidence,
mortality,
disability-adjusted
life
years
(DALYs)
for
the
2020
2021.
Methods
Data
DALYs,
mortality
were
derived
from
Global
Burden
Disease
Study
2019.
The
data
carefully
estimated
presented
in
both
numerical
values
age-standardized
rates
(ASRs)
per
100,000
individuals,
inclusive
95%
uncertainty
intervals
(UI).
study
further
stratified
burden
by
age,
gender,
sociodemographic
index
(SDI),
system
infrastructure.
Additionally,
correlation
between
ASR
SDI
was
examined.
Findings
There
marked
disparities
across
various
countries
regions
Globally,
number
DALYs
death
showed
increasing
trend
2021,
particularly
with
lower
less
robust
healthcare
Men
exhibited
higher
numbers
ASRs
death.
elderly
experienced
despite
having
lowest
incidence
rates.
Furthermore,
a
significant
negative
observed
21
204
countries.
Conclusion
This
highlights
pronounced
escalation
elderly,
males,
those
developed
systems
being
disproportionately
affected.
A
comprehensive
understanding
epidemiology
is
essential
devising
strategies
mitigate
disease's
impact.
Language: Английский
INTEGRATIVE INDICATORS OF ENDOGENOUS INTOXICATION, INFLAMMATORY ACTIVITY, AND SPECIFIC REACTIVITY IN PATIENTS WITH COVID-19
Інфекційні хвороби,
Journal Year:
2024,
Volume and Issue:
3, P. 21 - 27
Published: Oct. 11, 2024
The
aim
of
the
study
is
to
identify
changes
in
blood
laboratory
parameters,
integrative
indicators
endogenous
intoxication,
inflammation,
and
specific
reactivity
patients
with
coronavirus
disease.
Patients
methods.
included
77
COVID-19,
taking
into
account
inclusion
exclusion
criteria.
comparison
group
consisted
68
practically
healthy
people
corresponding
age.
Laboratory
tests
were
performed,
on
basis
which
inflammation
calculated.
Results.
data
general
test
showed
no
significant
differences
between
groups,
remained
within
acceptable
limits.
A
slight
inflammatory
reaction
especially
period
from
3
6
months,
confirmed
by
an
increase
level
intoxication
(LII,
LSI,
NLRI,
HII)
compared
individuals.
During
same
period,
there
are
signs
activation
cellular
immune
system
response
presence
latent
bacterial
infection
or
a
decrease
activity
(LGI,
LESRI,
CI).
Reduced
indices
nonspecific
(RC,
ILYM,
AI)
system,
given
number
lymphocytes
relative
granulocytes.
Changes
did
not
depend
Long-COVID
symptoms.
In
12
months
after
disease,
development
autoimmune
processes
possible,
since
was
tendency
(NLRI,
LSI)
simultaneously
TI)
Ilymph,
AI).
Language: Английский